Cetraxate
Cetraxate is an orally active antiulcer Drug. Cetraxate increases the blood flow of gastric mucosal. Cetraxate increases the eradication of Helicobacter pylori in smokers when in combination with Omeprazole , Amoxicillin (HY-B0467A), and Clarithromycin (HY-17508).
Product Specifications
CAS Number
34675-84-8
UNSPSC
12352005
Hazard Statement
H301-H311-H331
Target
Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/cetraxate.html
Solubility
10 mM in DMSO
Smiles
OC(CCC(C=C1)=CC=C1OC([C@H]2CC[C@@H](CC2)CN)=O)=O
Molecular Formula
C17H23NO4
Molecular Weight
305.37
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P330-P361+P364-P405-P501
References & Citations
[1]Kamada T, et al. Cetraxate, a mucosal protective agent, combined with omeprazole, amoxycillin, and clarithromycin increases the eradication rate of helicobacter pylori in smokers. Aliment Pharmacol Ther. 2000 Aug;14 (8) :1089-94.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Launched
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
OR1002130-01 100 mg
Methyl 3- (5- (benzylcarbamoyl) furan-2-yl) thiophene-2-carboxylate
Sign In for Pricing
View Details OR1002130-02 500 mg
Methyl 3- (5- (benzylcarbamoyl) furan-2-yl) thiophene-2-carboxylate
Sign In for Pricing
View Details OR1002130-03 1 g
Methyl 3- (5- (benzylcarbamoyl) furan-2-yl) thiophene-2-carboxylate
Sign In for Pricing
View Details 